|
Market Closed -
Xetra
19:35:18 18/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 5.500 EUR | -3.51% |
|
-3.51% | +48.65% |
Company Valuation: MEDICLIN AG
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 186.2 | 171 | 130.2 | 115 | 175.8 | 261.2 | - | - |
| Change | - | -8.16% | -23.89% | -11.68% | 52.89% | 48.65% | - | - |
| Enterprise Value (EV) | 186.2 | 171 | 130.2 | 115 | 175.8 | 261.2 | 261.2 | 261.2 |
| Change | - | -8.16% | -23.89% | -11.68% | 52.89% | 48.65% | 0% | 0% |
| P/E | - | - | - | - | - | - | - | - |
| PBR | 1.02x | 0.82x | 0.66x | 0.52x | 0.71x | 0.92x | 0.81x | 0.73x |
| PEG | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 0.28x | 0.24x | 0.18x | 0.15x | 0.22x | 0.33x | 0.33x | 0.32x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 0.33x | 0.33x | 0.32x |
| EV / EBITDA | 0x | 0x | 0x | 0x | 0x | 2.29x | 2.27x | 2.26x |
| EV / EBIT | 0x | 0x | 0x | 0x | 0x | 4.21x | 4.18x | 4.17x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | 0.04 | 0.04 | 0.04 | 0.04 |
| Rate of return | - | - | - | - | 1.08% | 0.73% | 0.73% | 0.73% |
| EPS 2 | - | - | - | - | - | - | - | - |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 673.1 | 704.7 | 730.1 | 748.8 | 784.5 | 787.5 | 803.2 | 819.3 |
| EBITDA 1 | 85.22 | 90.92 | 98.73 | 103.8 | 115.6 | 114.3 | 115.3 | 115.6 |
| EBIT 1 | 11.56 | 19.52 | 12.72 | 53.49 | 55.36 | 62.11 | 62.47 | 62.72 |
| Net income 1 | 1.461 | 9.441 | -10.78 | 24.84 | 25.49 | 36.66 | 38.2 | 40.12 |
| Net Debt | - | - | - | - | - | - | - | - |
| Reference price 2 | 3.920 | 3.600 | 2.740 | 2.420 | 3.700 | 5.500 | 5.500 | 5.500 |
| Nbr of stocks (in thousands) | 47,500 | 47,500 | 47,500 | 47,500 | 47,500 | 47,500 | - | - |
| Announcement Date | 30/03/22 | 31/03/23 | 27/03/24 | 28/03/25 | 27/03/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | 0.73% | 300M | ||
| 29.77x | 2.81x | 12.54x | 1.48% | 16.54B | ||
| 51.69x | 4.46x | 28.99x | 0.27% | 13.4B | ||
| 19.11x | 2.27x | 10.6x | 0.65% | 12.01B | ||
| 25.01x | 2.93x | 10.21x | 1.61% | 11.12B | ||
| 82.18x | 7.82x | 31.8x | - | 10.13B | ||
| 24.64x | 2x | 16.11x | 0.15% | 10.05B | ||
| 19.55x | 2.84x | 11.72x | 4.13% | 9.48B | ||
| 42.27x | 1.07x | 8.91x | 1.53% | 9.07B | ||
| 13.21x | 1.29x | 7.59x | 2% | 8.11B | ||
| Average | 34.16x | 3.05x | 15.38x | 1.4% | 10.02B | |
| Weighted average by Cap. | 34.52x | 3.13x | 15.76x | 1.39% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- MED Stock
- Valuation MEDICLIN AG
Select your edition
All financial news and data tailored to specific country editions
















